Person Dr Andrew Martin National Health and Medical Research Council Viewed: [[ro.stat.viewed]] Click to explore relationships graph Help Related Grants and Projects $relation_to_title = []; $dupes = 0;?> Participant in A phase II trial of follow-up of men with prostate cancer in primary care. (funded by National Health and Medical Research Council) Participant in CHEST Australia: reducing time to consult in primary care with symptoms of lung cancer. (funded by National Health and Medical Research Council) Participant in Does bovine lactoferrin (bLF) reduce mortality and morbidity in very low birthweight infants? (funded by National Health and Medical Research Council) Participant in Generating evidence of reduced rates of overweight/obesity in children: value adding to four established Australasian early intervention trials (funded by National Health and Medical Research Council) Participant in NEU-HORIZONS: The neuroprotection and therapeutic use of riluzole for the prevention of oxaliplatin neurotoxicity study. (funded by National Health and Medical Research Council) View all 7 related grants and projects User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover Saved to MyRDA Save to MyRDA
Click to explore relationships graph Help Related Grants and Projects $relation_to_title = []; $dupes = 0;?> Participant in A phase II trial of follow-up of men with prostate cancer in primary care. (funded by National Health and Medical Research Council) Participant in CHEST Australia: reducing time to consult in primary care with symptoms of lung cancer. (funded by National Health and Medical Research Council) Participant in Does bovine lactoferrin (bLF) reduce mortality and morbidity in very low birthweight infants? (funded by National Health and Medical Research Council) Participant in Generating evidence of reduced rates of overweight/obesity in children: value adding to four established Australasian early intervention trials (funded by National Health and Medical Research Council) Participant in NEU-HORIZONS: The neuroprotection and therapeutic use of riluzole for the prevention of oxaliplatin neurotoxicity study. (funded by National Health and Medical Research Council) View all 7 related grants and projects User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover